Contact dermatitis to phenylbutazone-piperazine suppositories (Carudol) and piperazine gel (Carudol).
D000328:Adult; D000368:Aged; D003877:Dermatitis, Contact / Q000209:etiology*; D005260:Female; D005782:Gels; D006801:Humans; D008297:Male; D010653:Phenylbutazone / Q000009:adverse effects*; D000077489:Piperazine; D010879:Piperazines / Q000009:adverse effects*; D013488:Suppositories
D005782:Gels; D010879:Piperazines; D013488:Suppositories; D000077489:Piperazine; D010653:Phenylbutazone